Advirna is a private biotechnology company developing innovative solutions for efficient delivery of polynucleotides in vivo. Our technology platform, self-deliverable RNAi, is based on the recent breakthrough in biology known as RNA interference (RNAi). This discovery opened a possibility to specifically regulate activity of genes inside a living cell.